SYRACUSE UNIVERSITY 
DEPARTMENT OF BIOLOGY | BIOLOGICAL RESEARCH LABORATORIES 
130 COLLECE PLACE | SYRACUSE, NEW YORK 13210 2878 
January 11, 1983 telephone 315 | 423 3186 
Dr. William J. Gartland, Jr. 
Department of Health & Human Services 
Public Health Service 
National Institutes of Health 
Bethesda, MD 20205 
Dear Dr. Gartland: 
This letter is in response to your request to answer a series of questions 
raised by RAC at their last June meeting. At Syracuse University research invol- 
ving recombinant DNA molecules has remained at the level established a few 
years ago and consequently is not affected by the revisions of the guidelines 
during 1982. Specific answers to your questions are: 
o We see no problems resulting from the revised guidelines, 
o No change in our present time investment. 
o Nothing in the administrative procedures requires an inordinate amount of time, 
o No disagreement with present containment requirements, 
o Guidelines are workable for our research purposes. 
o Our IBC has not been confronted with any research requests from P.I.s 
which require review of procedures for proposed research using 
recombinant DNA molecules. Consequently, we have not met; memos 
or phone calls have been adequate to maintain any business required. 
o The IBC at Syracuse does not, at this time, have any other responsibilities 
relative to safety. The Administration has chosen to function this way. 
Sincerely , 
Donald G . Lundgren 
Professor of Microbiology 
Chairman , IBC 
DGL : cs 
cc: Mr. Tom McGiff, 
Environmental Safety Officer 
[ 569 ] 
